Expression of matrix metalloproteinases MMP-2 and MMP-9 is altered during nephrogenesis in fetuses from diabetic rats

Laboratory Investigation

Volumn 87, Issue 7, 2007, Pages 680-689

  Duong Van Huyen, Jean Paul ^a,b   Viltard, Mélanie ^a   Nehiri, Touria ^a   Freund, Nicole ^a   Bélair, Marie France ^a   Martinerie, Cécile ^a   Lelongt, Brigitte ^a   Bruneval, Patrick ^a,b   Lelièvre Pégorier, Martine ^a  

^a INSERM   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Diabetes mellitus; Extracellular matrix; Metalloproteinase; Nephrogenesis

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; GELATINASE A; GELATINASE B; GLUCOSE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC KIDNEY DISEASE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; EMBRYO; FEMALE; FETUS; FETUS DEVELOPMENT; GENE EXPRESSION; GENE EXPRESSION REGULATION; HYPERTENSION; KIDNEY DEVELOPMENT; KIDNEY DISEASE; MALE; MATERNAL DIABETES MELLITUS; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMEDIATE-EARLY PROTEINS; IN SITU HYBRIDIZATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; ORGANOGENESIS; PREGNANCY; PREGNANCY IN DIABETICS; RATS; RATS, SPRAGUE-DAWLEY; STAINING AND LABELING; TRANSFORMING GROWTH FACTOR BETA1;

EID: 34250374470     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700562     Document Type: Article

References (48)

1. Horster MF, Braun GS, Huber SM. Embryonic renal epithelia: induction, nephrogenesis, and cell differentiation. Physiol Rev 1999;79:1157-1191.
2. Saxen L, Sariola H, Lehtonen E. Sequential cell and tissue interactions governing organogenesis of the kidney. Anat Embryol (Berl) 1986;175:1-6.
3. Kanwar Y, Liu Z, Wallner E. Influence of glucose on murine metanephric development and proteoglycans: morphologic and biochemical studies. Lab Invest 1997;76:671-681.
4. Kanwar YS, Wada J, Lin S, et al. Update of extracellular matrix, its receptors, and cell adhesion molecules in mammalian nephrogenesis. Am J Physiol 2004;286:F202-F215.
5. Andrews KL, Betsuyaku T, Rogers S, et al. Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome. Am J Pathol 2000;157:303-311.
6. Barasch J, Yang J, Qiao J, et al. Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros. J Clin Invest 1999;103:1299-1307.
7. Kanwar Y, Ota K, Yang Q, et al. Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis. Am J Physiol 1999;277(Renal Physiol 46):F934-F947.
8. Legallicier B, Trugnan G, Murphy G, et al. Expression of the type IV collagenase system during mouse kidney development and tubule segmentation. J Am Soc Nephrol 2001;12:2358-2369.
9. Lelongt B, Trugnan G, Murphy G, et al. Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro. J Cell Biol 1997;136:1363-1373.
10. Ota K, Stetler-Stevenson WG, Yang Q, et al. Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor. Kidney Int 1998;54:131-142.
11. Pohl M, Sakurai H, Bush KT, et al. Matrix metalloproteinases and their inhibitors regulate in vitro ureteric bud branching morphogenesis. Am J Physiol Renal Physiol 2000;279:F891-F900.
12. Reponen P, Sahlberg C, Huhtala P, et al. Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development. J Biol Chem 1992;267:7856-7862.
13. Fuhrmann K, Reiher H, Semmler K, et al. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care 1983;6:219-223.
14. Martinez-Frias ML. Epidemiological analysis of outcomes of pregnancy in diabetic mothers: identification of the most characteristic and most frequent congenital anomalies. Am J Med Genet 1994;51:108-113.
15. Lynch SA, Wright C. Sirenomelia, limb reduction defects, cardiovascular malformation, renal agenesis in an infant born to a diabetic mother. Clin Dysmorphol 1997;6:75-80.
16. Amri K, Freund N, Vilar J, et al. Adverse effects of hyperglycemia on kidney development in rats: in vivo and in vitro studies. Diabetes 1999;48:2240-2245.
17. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1988;1:335-347.
18. Ingelfinger JR, Schnaper HW. Renal endowment: developmental origins of adult disease. J Am Soc Nephrol 2005;16:2533-2536.
19. Lelièvre-Pégorier M, Merlet-Benichou C. The number of nephrons in the mammalian kidney: environmental influences play a determining role. Exp Nephrol 2000;8:63-65.
20. Schrijvers BF, De Vriese AS, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocrine Rev 2004;25:971-1010.
21. Fornoni A, Striker LJ, Zheng F, et al. Reversibility of glucose-induced changes in mesangial cell extracellular matrix depends on the genetic background. Diabetes 2002;51:499-505.
22. McLennan SV, Fisher EJ, Yue DK, et al. High glucose concentration causes a decrease in mesangium degradation. A factor in the pathogenesis of diabetic nephropathy. Diabetes 1994;43:1041-1045.
23. McLennan SV, Wang XY, Moreno V, et al. Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy. Endocrinology 2004;145:5646-5655.
24. Singh R, Song RH, Alavi N, et al. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1. Exp Nephrol 2001;9:249-257.
25. Kobayashi T, Inoue T, Okada H, et al. Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-beta produced by tubular epithelial cells in response to high glucose. Clin Exp Nephrol 2005;9:114-121.
26. Riser BL, Denichilo M, Cortes P, et al. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 2000;11:25-38.
27. Roestenberg P, van Nieuwenhoven FA, Joles JA, et al. Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice. Am J Physiol Renal Physiol 2006;290:F1344-F1354.
28. Li JH, Huang XR, Zhu HJ, et al. Role of TGF-beta signaling in extracellular matrix production under high glucose conditions. Kidney Int 2003;63:2010-2019.
29. Kanwar YS, Liu ZZ, Kumar A, et al. D-glucose-induced dysmorphogenesis of embryonic kidney. J Clin Invest 1996;98:2478-2488.
30. Wada J, Kanwar YS, Makino H. Relevance of extracellular matrix and its receptors in mammalian nephrogenesis revealed by metanephric organ culture system. Nephrol Dial Transplant 2002;17(Suppl 9):75-77.
31. McVary KT, Maizels M. Urinary obstruction reduces glomerulogenesis in the developing kidney: a model in the rabbit. J Urol 1989;142:646-651; discussion 67-68.
32. Vilar J, Gilbert T, Moreau E, et al. Metanephros organogenesis is highly stimulated by vitamin A derivatives in organ culture. Kidney Int 1996;49:1478-1487.
33. Guinobert I, Viltard M, Piquemal D, et al. Identification of differentially expressed genes between fetal and adult mouse kidney: candidate gene in kidney development. Nephron Physiol 2006;102:p81-p91.
34. Duong Van Huyen JP, Amri K, Belair MF, et al. Spatiotemporal distribution of insulin-like growth factor receptors during nephrogenesis in fetuses from normal and diabetic rats. Cell Tissue Res 2003;314:367-379.
35. Piedagnel R, Murphy G, Ronco PM, et al. Matrix metalloproteinase 2 (MMP2) and MMP9 are produced by kidney collecting duct principal cells but are differentially regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor. J Biol Chem 1999;274:1614-1620.
36. Lafont J, Jacques C, Le Dreau G, et al. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen. J Bone Miner Res 2005;20:2213-2223.
37. McCormick JJ, Blomquist JC, Rusch HP. Isolation and characterization of an extracellular polysaccharide from physarum polycephalum. J Bacteriol 1970;104:1110-1118.
38. Grobstein C, Cohen J. Collagenase: effect on the morphogenesis of embryonic salivary epithelium in vitro. Science 1965;150:626-628.
39. Wessells NK, Cohen JH. Effects of collagenase on developing epithelia in vitro: lung, ureteric bud, and pancreas. Dev Biol 1968;18:294-309.
40. Sakurai H, Nigam SK. Transforming growth factor-beta selectively inhibits branching morphogenesis but not tubulogenesis. Am J Physiol 1997;272:F139-F146.
41. Sakurai H, Barros EJ, Tsukamoto T, et al. An in vitro tubulogenesis system using cell lines derived from the embryonic kidney shows dependence on multiple soluble growth factors. Proc Natl Acad Sci USA 1997;94:6279-6284.
42. Shankland SJ, Ly H, Thai K, et al. Glomerular expression of tissue inhibitor of metalloproteinase (TIMP-1) in normal and diabetic rats. J Am Soc Nephrol 1996;7:97-104.
43. Bush KT, Sakurai H, Steer DL, et al. TGF-beta superfamily members modulate growth, branching, shaping, and patterning of the ureteric bud. Dev Biol 2004;266:285-298.
44. Schmid P, Cox D, Bilbe G, et al. Differential expression of TGF beta 1, beta 2 and beta 3 genes during mouse embryogenesis. Development 1991;111:117-130.
45. Vrljicak P, Myburgh D, Ryan AK, et al. Smad expression during kidney development. Am J Physiol Renal Physiol 2004;286:F625-F633.
46. Basile DP, Hammerman MR. TGF-beta in renal development and renal growth. Miner Electrolyte Metab 1998;24:144-148.
47. Rogers SA, Ryan G, Purchio AF, et al. Metanephric transforming growth factor-beta 1 regulates nephrogenesis in vitro. Am J Physiol 1993;264:996-F1002.
48. Amri K, Freund N, Van Huyen JP, et al. Altered nephrogenesis due to maternal diabetes is associated with increased expression of IGF-II/mannose-6-phosphate receptor in the fetal kidney. Diabetes 2001;50:1069-1075.